ArticleFrontiers in pharmacology2022

The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter.

Han Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.